Thursday, October 29, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

BellChild Co.,Ltd. Estimates – TSE:503A

Explore reported financial data and analyst estimates across the income statement, balance sheet, cash flow statement, and valuation metrics. Compare actual results with average,…

DO
By Daniel Okafor · Regulatory Correspondent
Oct 27 09:53 ETSource: TradingView

From the source

BellChild Co.,Ltd. Estimates – TSE:503A

Explore reported financial data and analyst estimates across the income statement, balance sheet, cash flow statement, and valuation metrics. Compare actual results with average, high, and low estimates, and visualize trends over time.

Read at tradingview.com
PeptiPrescribed peptides from $99/moSee all →